-
公开(公告)号:US20080108820A1
公开(公告)日:2008-05-08
申请号:US10572871
申请日:2004-09-22
Applicant: Silvio A. Campagna , Francis G. Fang , James J. Kowalczyk , Shawn Schiller , Boris M. Seletsky , Mark Spyvee , Hu Yang
Inventor: Silvio A. Campagna , Francis G. Fang , James J. Kowalczyk , Shawn Schiller , Boris M. Seletsky , Mark Spyvee , Hu Yang
IPC: C07D211/60 , C07D277/06
CPC classification number: C07D207/04 , C07D207/12 , C07D207/16 , C07D207/42 , C07D209/20 , C07D211/60 , C07D217/26 , C07D223/06 , C07D233/84 , C07D237/04 , C07D241/04 , C07D265/30 , C07D277/06 , C07D279/12 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D405/12 , C07D471/04 , C07K5/0205 , C07K5/0207 , C07K5/0821
Abstract: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.
Abstract translation: 本发明提供具有式(I)的化合物:另外提供其合成方法及其用于治疗癌症的方法,其中R 1 -R 7 X 1,X 2,R 3,Q 3和n如本文所定义。
-
32.Compounds and methods for treating Toll-like receptor 2-related diseases and conditions 失效
Title translation: 治疗Toll样受体2相关疾病和病症的化合物和方法公开(公告)号:US07202234B2
公开(公告)日:2007-04-10
申请号:US10973164
申请日:2004-10-25
Applicant: Jesse Chow , Fabian Gusovksy , Lynn Hawkins , Mark Spyvee
Inventor: Jesse Chow , Fabian Gusovksy , Lynn Hawkins , Mark Spyvee
IPC: C07F9/02 , C07F9/08 , A61K31/675 , A61K31/66
CPC classification number: A61K31/661 , A61K31/4045 , C07F9/02 , C07F9/091 , C07F9/5728
Abstract: The present invention relates to compounds and methods useful in the prevention or treatment of diseases or conditions associated with Toll-like receptor 2 activation.
Abstract translation: 本发明涉及可用于预防或治疗与Toll样受体2激活相关的疾病或病症的化合物和方法。
-
公开(公告)号:US08691814B2
公开(公告)日:2014-04-08
申请号:US12917669
申请日:2010-11-02
Applicant: Jane Daun , Heather A. Davis , Bruce DeCosta , Fabian Gusovsky , Ieharu Hishinuma , Yimin Jiang , Toshihiko Kaneko , Kouichi Kikuchi , Seiichi Kobayashi , André Lescarbeau , Xiang-Yi Li , Kenzo Muramoto , Norihito Ohi , Marc Pesant , Boris M. Seletsky , Motohiro Soejima , Mark Spyvee , Lynda Tremblay , Ye Yao , Hiromitsu Yokohama , Yan (Janet) Zhao , Wanjun Zheng
Inventor: Jane Daun , Heather A. Davis , Bruce DeCosta , Fabian Gusovsky , Ieharu Hishinuma , Yimin Jiang , Toshihiko Kaneko , Kouichi Kikuchi , Seiichi Kobayashi , André Lescarbeau , Xiang-Yi Li , Kenzo Muramoto , Norihito Ohi , Marc Pesant , Boris M. Seletsky , Motohiro Soejima , Mark Spyvee , Lynda Tremblay , Ye Yao , Hiromitsu Yokohama , Yan (Janet) Zhao , Wanjun Zheng
IPC: A61K31/437 , A61K31/496 , A61K31/4545 , A61K31/444 , A61P35/00
CPC classification number: A61K31/437 , C07D471/04
Abstract: The present invention provides compounds having formula (I): wherein R1, R2, R3 and n are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of inflammatory or autoimmune and proliferative disorders and as inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction generally.
Abstract translation: 本发明提供了具有式(I)的化合物:其中R 1,R 2,R 3和n如本文中一般和本领域和亚类所述,并且另外提供其药物组合物,及其用于治疗炎症或自身免疫的方法 和增殖性疾病以及作为细胞粘附分子表达和炎性细胞因子信号转导的抑制剂。
-
公开(公告)号:US08354400B2
公开(公告)日:2013-01-15
申请号:US13121012
申请日:2009-09-25
Applicant: Wanjun Zheng , Mark Spyvee , Fabian Gusovsky , Sally T. Ishizaka
Inventor: Wanjun Zheng , Mark Spyvee , Fabian Gusovsky , Sally T. Ishizaka
IPC: A61K31/551 , A61K31/5355 , A61K31/496 , A61K31/4402 , A61K31/4409 , A61K31/443 , A61K31/4453 , A61K31/4468 , A61K31/428
CPC classification number: C07D263/56 , C07D413/12
Abstract: The present invention provides benzoxazole compounds and pharmaceutically acceptable salts thereof and pharmaceutical compositions including the same. The present invention further provides methods of use as described herein.
Abstract translation: 本发明提供苯并恶唑化合物及其药学上可接受的盐以及包含它们的药物组合物。 本发明进一步提供如本文所述的使用方法。
-
35.HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER 失效
Title translation: 肾上腺素衍生物及其在治疗癌症中的用途公开(公告)号:US20120309938A1
公开(公告)日:2012-12-06
申请号:US13365728
申请日:2012-02-03
Applicant: James J. KOWALCZYK , Galina KUZNETSOV , Shawn SCHILLER , Boris M. SELETSKY , Mark SPYVEE , Hu YANG
Inventor: James J. KOWALCZYK , Galina KUZNETSOV , Shawn SCHILLER , Boris M. SELETSKY , Mark SPYVEE , Hu YANG
CPC classification number: C07K7/06 , A61K38/05 , A61K38/06 , A61K38/07 , A61K38/08 , C07C237/22 , C07D207/08 , C07D207/16 , C07D211/60 , C07D295/185 , C07D401/14 , C07K5/06078 , C07K5/06156 , C07K5/06165 , C07K5/0808 , C07K5/0821 , C07K5/0823 , C07K5/1016
Abstract: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.
Abstract translation: 本发明提供具有式(I)的化合物:另外提供其合成方法及其用于治疗癌症的方法,其中R1-R7,X1,X2,R,Q和n如本文所定义 。
-
36.Compounds and methods for treating toll-like receptor 2-related diseases and conditions 失效
Title translation: 用于治疗类风湿关节炎2型相关疾病和病症的化合物和方法公开(公告)号:US07838548B2
公开(公告)日:2010-11-23
申请号:US12416489
申请日:2009-04-01
Applicant: Jesse Chow , Fabian Gusovksy , Lynn Hawkins , Mark Spyvee
Inventor: Jesse Chow , Fabian Gusovksy , Lynn Hawkins , Mark Spyvee
IPC: A61K31/4045 , A61K31/404 , C07D209/18
CPC classification number: A61K31/661 , A61K31/4045 , C07F9/02 , C07F9/091 , C07F9/5728
Abstract: The present invention relates to compounds and methods useful in the prevention or treatment of diseases or conditions associated with Toll-like receptor 2 activation.
Abstract translation: 本发明涉及可用于预防或治疗与Toll样受体2激活相关的疾病或病症的化合物和方法。
-
公开(公告)号:US07799827B2
公开(公告)日:2010-09-21
申请号:US10507067
申请日:2003-03-07
Applicant: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-André Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
Inventor: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-André Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
IPC: A61K31/335 , C07D313/00
CPC classification number: C07D405/12 , A61K31/335 , A61K31/36 , A61K31/395 , C07D231/12 , C07D233/56 , C07D249/08 , C07D313/00 , C07D401/12 , C07D491/04 , C07D491/044 , C07D493/04 , Y02A50/411
Abstract: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, X, Y, Z, and n are as defined herein.
Abstract translation: 本发明提供了具有式(I)的化合物:另外提供了其合成方法及其用于治疗各种疾病(包括炎性或自身免疫性疾病以及涉及恶性肿瘤或增加血管发生的疾病)的方法,其中R1-R11, X,Y,Z和n如本文所定义。
-
公开(公告)号:US20100113446A1
公开(公告)日:2010-05-06
申请号:US12652314
申请日:2010-01-05
Applicant: Brian M. Gallagher, JR. , Eric Carlson , Qian Chen , Heather Davis , Shawn Schiller , Christina Shaffer , Mark Spyvee , Nancy Wong
Inventor: Brian M. Gallagher, JR. , Eric Carlson , Qian Chen , Heather Davis , Shawn Schiller , Christina Shaffer , Mark Spyvee , Nancy Wong
IPC: A61K31/5377 , A61K31/438 , C07D498/10 , C07D471/10 , A61P29/02 , A61P25/28
CPC classification number: C07D471/10
Abstract: The invention relates to the use of hydantoin compounds useful for treating or preventing autoimmune disorders. The present invention also provides compositions and uses thereof.
Abstract translation: 本发明涉及可用于治疗或预防自身免疫性疾病的乙内酰脲化合物的用途。 本发明还提供其组合物和用途。
-
公开(公告)号:US20090233906A1
公开(公告)日:2009-09-17
申请号:US12299855
申请日:2007-05-23
Applicant: Francis Fang , Shawn Schiller , Boris Seletsky , Mark Spyvee
Inventor: Francis Fang , Shawn Schiller , Boris Seletsky , Mark Spyvee
IPC: A61K31/55 , C07D487/20 , A61P19/02 , A61P37/00 , A61P25/00
CPC classification number: C07D471/20
Abstract: The invention relates to compounds of formula (I): along with pharmaceutical compositions containing the same and methods of use thereof.
Abstract translation: 本发明涉及式(I)化合物:以及含有其的药物组合物及其使用方法。
-
40.Compounds and methods for treating toll-like receptor 2-related diseases and conditions 失效
Title translation: 用于治疗类风湿关节炎2型相关疾病和病症的化合物和方法公开(公告)号:US07550501B2
公开(公告)日:2009-06-23
申请号:US11697651
申请日:2007-04-06
Applicant: Jesse Chow , Fabian Gusovksy , Lynn Hawkins , Mark Spyvee
Inventor: Jesse Chow , Fabian Gusovksy , Lynn Hawkins , Mark Spyvee
IPC: A61K31/661 , A61K31/4045
CPC classification number: A61K31/661 , A61K31/4045 , C07F9/02 , C07F9/091 , C07F9/5728
Abstract: The present invention relates to compounds and methods useful in the prevention or treatment of diseases or conditions associated with Toll-like receptor 2 activation.
Abstract translation: 本发明涉及可用于预防或治疗与Toll样受体2激活相关的疾病或病症的化合物和方法。
-
-
-
-
-
-
-
-
-